These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 29018531)
1. Magnetic resonance imaging to detect local tissue reactions after vaccination in sheep in vivo. Bernau M; Kremer-Rücker PV; Kreuzer LS; Schwanitz S; Cussler K; Hoffmann A; Scholz AM Vet Rec Open; 2017; 4(1):e000200. PubMed ID: 29018531 [TBL] [Abstract][Full Text] [Related]
2. Safety testing of veterinary vaccines using magnetic resonance imaging in pigs. Bernau M; Kremer PV; Pappenberger E; Kreuzer LS; Cussler K; Hoffmann A; Scholz AM ALTEX; 2015; 32(1):51-8. PubMed ID: 25490532 [TBL] [Abstract][Full Text] [Related]
3. Needle size for vaccination procedures in children and adolescents. Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010720. PubMed ID: 30091147 [TBL] [Abstract][Full Text] [Related]
4. Needle size for vaccination procedures in children and adolescents. Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647 [TBL] [Abstract][Full Text] [Related]
5. Assessment of local reaction to vaccines in live piglets with magnetic resonance imaging compared to histopathology. Bernau M; Kremer PV; Kreuzer LS; Emrich D; Pappenberger E; Cussler K; Hoffmann A; Leipig M; Hermanns W; Scholz AM ALTEX; 2016; 33(1):29-36. PubMed ID: 26537428 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study. Chen WH; Neuzil KM; Boyce CR; Pasetti MF; Reymann MK; Martellet L; Hosken N; LaForce FM; Dhere RM; Pisal SS; Chaudhari A; Kulkarni PS; Borrow R; Findlow H; Brown V; McDonough ML; Dally L; Alderson MR Lancet Infect Dis; 2018 Oct; 18(10):1088-1096. PubMed ID: 30120069 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Vaccine safety testing using magnetic resonance imaging in suckling pigs. Bernau M; Liesner BG; Schwanitz S; Kraus AS; Falkenau A; Leipig-Rudolph M; Hermanns W; Scholz AM Vaccine; 2018 Mar; 36(13):1789-1795. PubMed ID: 29472133 [TBL] [Abstract][Full Text] [Related]
10. Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study. Werner F; Zeschick N; Kühlein T; Steininger P; Überla K; Kaiser I; Sebastião M; Hueber S; Warkentin L BMC Med; 2023 Sep; 21(1):358. PubMed ID: 37726711 [TBL] [Abstract][Full Text] [Related]
11. The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines. Stanford K; Brogden KA; McClelland LA; Kozub GC; Audibert F Can J Vet Res; 1998 Jan; 62(1):38-43. PubMed ID: 9442938 [TBL] [Abstract][Full Text] [Related]
12. A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart. Nicholson KG; Abrams KR; Batham S; Clark TW; Hoschler K; Lim WS; Medina M; Nguyen-Van-Tam JS; Read RC; Warren FC; Zambon M Health Technol Assess; 2010 Dec; 14(55):193-334. PubMed ID: 21208550 [TBL] [Abstract][Full Text] [Related]
13. Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. Schmader KE; Liu CK; Harrington T; Rountree W; Auerbach H; Walter EB; Barnett ED; Schlaudecker EP; Todd CA; Poniewierski M; Staat MA; Wodi P; Broder KR JAMA Netw Open; 2021 Jan; 4(1):e2031266. PubMed ID: 33443580 [TBL] [Abstract][Full Text] [Related]
14. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial. Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843 [TBL] [Abstract][Full Text] [Related]
15. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial. Fu Q; Xie H; Zhou L; Li X; Liu Y; Liu M; Wang C; Wang X; Wang Z; Tang J; Xiao H; Xiao Z; Zhou J; Feng C; Wang L; Ao Z; Chen X; Su C; Wu X; Zhao M; Hu S; Lin H; Huang J; Xu G; Zhang Q; Jiang L Trials; 2021 Feb; 22(1):162. PubMed ID: 33632286 [TBL] [Abstract][Full Text] [Related]
16. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the local safety of two multi-component feline vaccines, adjuvanted (1 mL) versus non-adjuvanted at reduced volume (0.5 mL), using computed tomography imaging. Haist V; Bellebeau-Barbier F; Montange C; Lemaitre L; Diawara A; Guiot AL; Nicolier A; Latronico E; Chereul E; Brunet S; Tronel JP Vaccine; 2023 Jul; 41(32):4752-4761. PubMed ID: 37355451 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a killed vaccine for the control of paratuberculosis in Australian sheep flocks. Reddacliff L; Eppleston J; Windsor P; Whittington R; Jones S Vet Microbiol; 2006 Jun; 115(1-3):77-90. PubMed ID: 16459030 [TBL] [Abstract][Full Text] [Related]
19. Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine. Hopf S; Garner-Spitzer E; Hofer M; Kundi M; Wiedermann U Vaccine; 2016 Apr; 34(17):2027-34. PubMed ID: 26768126 [TBL] [Abstract][Full Text] [Related]
20. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs. J Vis Exp; 2023 May; (195):. PubMed ID: 37235796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]